iHuman Inc. (IH)
iHuman Statistics
Share Statistics
iHuman has 10.44M shares outstanding. The number of shares has increased by 118.13% in one year.
| Shares Outstanding | 10.44M |
| Shares Change (YoY) | 118.13% |
| Shares Change (QoQ) | 11.88% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 15.36M |
| Failed to Deliver (FTD) Shares | 292 |
| FTD / Avg. Volume | 0.38% |
Short Selling Information
The latest short interest is 3.66K, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 3.66K |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0% |
| Short Ratio (days to cover) | 0.15 |
Valuation Ratios
The PE ratio is 6.73 and the forward PE ratio is 8.58. iHuman's PEG ratio is 0.11.
| PE Ratio | 6.73 |
| Forward PE | 8.58 |
| PS Ratio | 1.2 |
| Forward PS | 0 |
| PB Ratio | 1.27 |
| P/FCF Ratio | 7.35 |
| PEG Ratio | 0.11 |
Enterprise Valuation
iHuman Inc. has an Enterprise Value (EV) of 7.9M.
| EV / Earnings | 0.04 |
| EV / Sales | 0.01 |
| EV / EBITDA | 0.05 |
| EV / EBIT | 0.05 |
| EV / FCF | 0.05 |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.
| Current Ratio | 2.82 |
| Quick Ratio | 2.78 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0.4 |
| Cash Flow / Debt | 44.59 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.19% and return on capital (ROIC) is 14.85%.
| Return on Equity (ROE) | 0.19% |
| Return on Assets (ROA) | 0.12% |
| Return on Capital (ROIC) | 14.85% |
| Revenue Per Employee | $1,300,305.24 |
| Profits Per Employee | $231,043.42 |
| Employee Count | 783 |
| Asset Turnover | 0.7 |
| Inventory Turnover | 17.97 |
Taxes
| Income Tax | 21.67M |
| Effective Tax Rate | 0.11 |
Stock Price Statistics
The stock price has increased by 40.59% in the last 52 weeks. The beta is 0.37, so iHuman's price volatility has been higher than the market average.
| Beta | 0.37 |
| 52-Week Price Change | 40.59% |
| 50-Day Moving Average | 2.04 |
| 200-Day Moving Average | 1.8 |
| Relative Strength Index (RSI) | 50.86 |
| Average Volume (20 Days) | 77.75K |
Income Statement
In the last 12 months, iHuman had revenue of 1.02B and earned 180.91M in profits. Earnings per share was 0.66.
| Revenue | 1.02B |
| Gross Profit | 721.27M |
| Operating Income | 159.89M |
| Net Income | 180.91M |
| EBITDA | 171.58M |
| EBIT | 159.89M |
| Earnings Per Share (EPS) | 0.66 |
Balance Sheet
The company has 1.21B in cash and 3.86M in debt, giving a net cash position of 1.21B.
| Cash & Cash Equivalents | 1.21B |
| Total Debt | 3.86M |
| Net Cash | 1.21B |
| Retained Earnings | -140.46M |
| Total Assets | 1.42B |
| Working Capital | 862.41M |
Cash Flow
In the last 12 months, operating cash flow was 172.12M and capital expenditures -6.51M, giving a free cash flow of 165.61M.
| Operating Cash Flow | 172.12M |
| Capital Expenditures | -6.51M |
| Free Cash Flow | 165.61M |
| FCF Per Share | 0.6 |
Margins
Gross margin is 70.84%, with operating and profit margins of 15.7% and 17.77%.
| Gross Margin | 70.84% |
| Operating Margin | 15.7% |
| Pretax Margin | 19.9% |
| Profit Margin | 17.77% |
| EBITDA Margin | 16.85% |
| EBIT Margin | 15.7% |
| FCF Margin | 16.27% |
Dividends & Yields
IH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 27.62% |
| FCF Yield | 663.47% |
Analyst Forecast
Currently there are no analyst rating for IH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 1.53 |
| Piotroski F-Score | 3 |